Search by Drug Name or NDC
NDC 23155-0518-41 Neostigmine Methylsulfate 1 mg/mL Details
Neostigmine Methylsulfate 1 mg/mL
Neostigmine Methylsulfate is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.. The primary component is NEOSTIGMINE METHYLSULFATE.
Product Information
| NDC | 23155-0518 |
|---|---|
| Product ID | 23155-518_e9bb7268-bb58-4aa5-aacf-9f1202436e77 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Neostigmine Methylsulfate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Neostigmine Methylsulfate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 1 |
| Active Ingredient Units | mg/mL |
| Substance Name | NEOSTIGMINE METHYLSULFATE |
| Labeler Name | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Pharmaceutical Class | Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA208230 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 23155-0518-41 (23155051841)
| NDC Package Code | 23155-518-41 |
|---|---|
| Billing NDC | 23155051841 |
| Package | 10 VIAL in 1 CARTON (23155-518-41) / 10 mL in 1 VIAL (23155-518-31) |
| Marketing Start Date | 2022-11-25 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |